Market Cap 995.93M
Revenue (ttm) 332.07M
Net Income (ttm) 18.25M
EPS (ttm) N/A
PE Ratio 139.28
Forward PE N/A
Profit Margin 5.50%
Debt to Equity Ratio 0.02
Volume 483,700
Avg Vol 378,068
Day's Range N/A - N/A
Shares Out 29.19M
Stochastic %K 78%
Beta 1.12
Analysts Strong Sell
Price Target $37.25

Company Profile

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 866 788 9007
Address:
505 S. Friendswood Drive, Suite 401, Friendswood, United States
THUNDERMAN01
THUNDERMAN01 Nov. 14 at 12:07 PM
$CSTL - New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node PositivitySecond study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify patients with a negative sentinel lymph node who have a higher risk of poor outcomes
0 · Reply
Leadballoon
Leadballoon Nov. 8 at 3:15 AM
$CSTL https://www.youtube.com/watch?v=uqZZIDk2c_Y MaetSOLD curse.
0 · Reply
Leadballoon
Leadballoon Nov. 7 at 11:50 AM
$CSTL Flurries, waves, pounding of keyboards- Cramer voice SELL, SELL, SELL coming in the next week from MaetSOLD= never fails.
1 · Reply
BioTechNoir
BioTechNoir Nov. 5 at 5:10 PM
$CSTL RUNNER!!
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 4:01 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 9:48 AM
BTIG has adjusted their stance on Castle Biosciences ( $CSTL ), setting the rating to Buy with a target price of 32 → 38.
0 · Reply
LucasHaynes
LucasHaynes Nov. 5 at 4:58 AM
Looking for the next parabolic runner?? Make sure to keep eyes on ticker VEEE .💎 VEEE catching serious attention after that $4.X.25M property sale. Tiny float✅ Clean balance sheet✅ Not many tickers trading under $3.X with real assets and no debt VEE is one💎 The setup here is one of a kind, this has the look to go massive. Make sure not to miss out tomorrow bulls! $CSTL $APUS $RDGT $RANI...8
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 7:15 PM
$CSTL strong watch at these levels
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 6:41 PM
$CSTL showing high relative strength....
0 · Reply
trademaster2121
trademaster2121 Nov. 4 at 6:40 PM
$CSTL what’s the chance this hits ATH by EOY?
2 · Reply
Latest News on CSTL
Why Castle Biosciences' Rally Might Just Be Getting Started

Nov 5, 2025, 8:02 AM EST - 9 days ago

Why Castle Biosciences' Rally Might Just Be Getting Started


Castle Biosciences Reports Third Quarter 2025 Results

Nov 3, 2025, 4:07 PM EST - 11 days ago

Castle Biosciences Reports Third Quarter 2025 Results


Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 10:21 PM EDT - 3 months ago

Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript


Castle Biosciences Reports Second Quarter 2025 Results

Aug 4, 2025, 4:05 PM EDT - 3 months ago

Castle Biosciences Reports Second Quarter 2025 Results


Castle Biosciences Celebrates Skin Cancer Awareness Month

May 7, 2025, 7:00 AM EDT - 6 months ago

Castle Biosciences Celebrates Skin Cancer Awareness Month


Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:58 PM EDT - 6 months ago

Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript


Castle Biosciences Reports First Quarter 2025 Results

May 5, 2025, 4:06 PM EDT - 6 months ago

Castle Biosciences Reports First Quarter 2025 Results


Castle Biosciences to Acquire Previse

May 5, 2025, 4:05 PM EDT - 6 months ago

Castle Biosciences to Acquire Previse


Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:09 PM EST - 9 months ago

Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript


THUNDERMAN01
THUNDERMAN01 Nov. 14 at 12:07 PM
$CSTL - New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node PositivitySecond study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify patients with a negative sentinel lymph node who have a higher risk of poor outcomes
0 · Reply
Leadballoon
Leadballoon Nov. 8 at 3:15 AM
$CSTL https://www.youtube.com/watch?v=uqZZIDk2c_Y MaetSOLD curse.
0 · Reply
Leadballoon
Leadballoon Nov. 7 at 11:50 AM
$CSTL Flurries, waves, pounding of keyboards- Cramer voice SELL, SELL, SELL coming in the next week from MaetSOLD= never fails.
1 · Reply
BioTechNoir
BioTechNoir Nov. 5 at 5:10 PM
$CSTL RUNNER!!
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 4:01 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 9:48 AM
BTIG has adjusted their stance on Castle Biosciences ( $CSTL ), setting the rating to Buy with a target price of 32 → 38.
0 · Reply
LucasHaynes
LucasHaynes Nov. 5 at 4:58 AM
Looking for the next parabolic runner?? Make sure to keep eyes on ticker VEEE .💎 VEEE catching serious attention after that $4.X.25M property sale. Tiny float✅ Clean balance sheet✅ Not many tickers trading under $3.X with real assets and no debt VEE is one💎 The setup here is one of a kind, this has the look to go massive. Make sure not to miss out tomorrow bulls! $CSTL $APUS $RDGT $RANI...8
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 7:15 PM
$CSTL strong watch at these levels
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 6:41 PM
$CSTL showing high relative strength....
0 · Reply
trademaster2121
trademaster2121 Nov. 4 at 6:40 PM
$CSTL what’s the chance this hits ATH by EOY?
2 · Reply
cranio_verde
cranio_verde Nov. 4 at 6:02 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 5:19 PM
Baird has adjusted their stance on Castle Biosciences ( $CSTL ), setting the rating to Outperform with a target price of 39 → 41.
0 · Reply
Okadarlan
Okadarlan Nov. 4 at 4:35 PM
$CSTL high price 34/// low price 19 ... short.
0 · Reply
IN0V8
IN0V8 Nov. 4 at 4:28 PM
$CSTL Revenues were $83 mil, compared to $85.8 million in the 3rd quarter of 24. Gross margin was 75%, and Adjusted Gross Margin was 77%, compared to 79% and 82%, respectively, for the same periods in 24. Net cash provided by operations was $22.6 million, compared to $23.3 million for the same period in 24. Net loss, which includes non-cash stock-based compensation expense of $12.1 million, was $0.5 million, compared to net income of $2.X.3 million for the same period in 24. Net loss per share and Adjusted Net Loss per Share, Basic and Diluted, was $0.02, compared to net income per share and Adjusted Net Income per Share, Basic and Diluted, of $0.08, for the same period in 24. Adjusted EBITDA was $9.2 million, compared to $21.6 million for the same period in 24.
0 · Reply
BioTechNoir
BioTechNoir Nov. 4 at 3:56 PM
$CSTL will be interested to see analyst updates on new test and financials after the call
0 · Reply
RocketThief
RocketThief Nov. 4 at 2:33 PM
$CSTL truth
0 · Reply
Cookem_up09
Cookem_up09 Nov. 3 at 10:31 PM
0 · Reply
BioTechNoir
BioTechNoir Nov. 3 at 10:29 PM
$CSTL https://ir.castlebiosciences.com/news/news-details/2025/Castle-Biosciences-Launches-AdvanceAD-Tx-to-Help-Guide-Systemic-Treatment-Decision-Making-in-Patients-with-Moderate-to-Severe-Atopic-Dermatitis/default.aspx
0 · Reply
Dream2121
Dream2121 Nov. 3 at 10:23 PM
$CSTL This company beats it's own guidance very badly every quarter!!!
0 · Reply
cranio_verde
cranio_verde Nov. 3 at 12:47 PM
1 · Reply
StockConsultant
StockConsultant Nov. 1 at 10:55 PM
$CSTL Castle Biosciences stock, nice close and top of range breakout, from Stocks to Watch
0 · Reply
RocketThief
RocketThief Oct. 22 at 2:52 PM
$CSTL strong heading into earnings, and they never miss
1 · Reply